- Treatment of Myasthenia Gravis Based on Its Immunopathogenesis
-
Kim JY, Park KD, Richman DP
- KMID: 2179002
- J Clin Neurol.
- 2011 Dec;7(4):173-183.
- doi: 10.3988/jcn.2011.7.4.173
The prognosis of myasthenia gravis (MG) has improved dramatically due to advances in critical-care medicine and symptomatic treatments. Its immunopathogenesis is fundamentally a T-cell-dependent autoimmune process resulting from loss of... -
- CITED
-
- Close
- SHARE
-
- Close
